Latest operating income for ZY: $-340M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2022
Trailing 12 months ending Jun 30, 2022
Zymergen (ZY) currently reports a operating income of $-340M as of June 2022. That compares with $-290M in the prior-year period — down 14.6% year over year. Use the charts on this page to explore Zymergen's operating income history and peer comparisons.
Zymergen's operating income decreased from $-290M to $-340M — a 14.6% year-over-year decrease (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zymergen reported $-340M in operating income as of June 2022. That compares with $-290M in the prior-year period — down 14.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $-340M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zymergen, and consider following ZY for alerts when major investors trade the stock.
Zymergen is classified in the Materials sector. On operating income, it currently shows $-340M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing ZY with unrelated industries.